CN103610200A - 一种抗癌保健口服液及其制作方法 - Google Patents
一种抗癌保健口服液及其制作方法 Download PDFInfo
- Publication number
- CN103610200A CN103610200A CN201310670653.6A CN201310670653A CN103610200A CN 103610200 A CN103610200 A CN 103610200A CN 201310670653 A CN201310670653 A CN 201310670653A CN 103610200 A CN103610200 A CN 103610200A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- preparation
- health
- care oral
- anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 17
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 12
- 235000008397 ginger Nutrition 0.000 claims abstract description 12
- 240000002234 Allium sativum Species 0.000 claims abstract description 11
- 235000004611 garlic Nutrition 0.000 claims abstract description 11
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 8
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 8
- 229940109850 royal jelly Drugs 0.000 claims abstract description 8
- 239000000052 vinegar Substances 0.000 claims abstract description 7
- 235000021419 vinegar Nutrition 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract 2
- 239000012530 fluid Substances 0.000 claims description 12
- 241000411851 herbal medicine Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 241000234314 Zingiber Species 0.000 claims description 10
- 210000000689 upper leg Anatomy 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 235000009508 confectionery Nutrition 0.000 abstract description 6
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 4
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 4
- 235000013361 beverage Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 241000700605 Viruses Species 0.000 abstract description 2
- 235000006533 astragalus Nutrition 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BJBUTJQYZDYRMJ-UHFFFAOYSA-N Kaempferol 3,7-dimethyl ether Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C=C1 BJBUTJQYZDYRMJ-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- -1 antiallergy Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种保健饮品及其制作方法,具体涉及一种抗癌保健口服液及其制作方法。取黄芪、当归、三七、纹股蓝煎制成水溶剂,与苹果醋蜂王浆混合均匀后,将大蒜、生姜、酸梅放入其中浸泡制成,长期饮用本发明制出的口服液能使人体具有抗癌能力,增强免疫力,无任何副作用和不良反应,口味酸甜,能防止外界病毒对人体造成的伤害,同时还能起到降压、降血脂的功效。
Description
技术领域
本发明涉及一种保健饮品及其制作方法,具体涉及一种抗癌保健口服液及其制作方法。
背景技术
症是一大类恶性肿瘤的统称。癌细胞的特点是无限制、无止境地增生,使患者体内的营养物质被大量消耗;癌细胞释放出多种毒素,使人体产生一系列症状;癌细胞还可转移到全身各处生长繁殖,导致人体消瘦、无力、贫血、食欲不振、发热以及严重的脏器功能受损等等。与之相对的有良性肿瘤,良性肿瘤则容易清除干净,一般不转移、不复发,对器官、组织只有挤压和阻塞作用,但癌症(恶性肿瘤)还可破坏组织、器官的结构和功能,引起坏死出血合并感染,患者最终由于器官功能衰竭而死亡。
癌症的出现与我们不良的日常饮食有很大的关联,目前市场上有许多保健饮品,但这些饮品功能单一,抗癌保健效果不明显,而且味道不好,人们不愿意经常服用。
发明内容
为解决上述问题,本房卖给您提供一种抗癌保健口服液及其制作方法。
本发明采用的技术方案为:一种抗癌保健口服液,其特征在于:其组成为:
每200ml抗癌保健口服液中含有:
大蒜 10-25g
生姜 10-25g
酸梅 10-25g
蜂王浆 10-15g
中草药液 50ml
苹果醋 150ml
其中,所述中草药液所含组分为:
黄芪 5-10g
当归 5-10g
三七 5-10g
纹股蓝 5-10g
一种保健口服液的制作方法,其特征在于:
a、中草药液的制备:取黄芪5-10g、当归5-10g、三七5-10g、纹股蓝5-10g洗净后进行煎煮,浓缩至50ml备用;
b、将100ml苹果醋、50ml中草药液混合,加入10-15g蜂王浆混合均匀,放入大蒜10-25g、生姜10-25g、酸梅10-25g,低温杀菌后,在2-3℃下浸泡10-15天,滤除大蒜、生姜、酸梅,装入瓶中即可。
大蒜性温、辛、甘,可保护肝脏,调节血糖,保护心血管,抗高血脂和动脉硬化,抗血小板凝集。营养学专家发现,大蒜提取液有抗肿瘤的作用。
生姜功效:祛风、解表、和胃、温经止痛。作用:有明显解热、抗菌、消炎作用;有镇静、止吐、抗过敏、抗血小板聚集作用;水浸剂在试管内有杀灭阴道滴虫作用;姜汁对多种致病真菌有抑制作用;水浸剂对多种病原菌有强大杀菌作用。
酸梅的果实含有丰富的柠檬酸和苹果酸,酸味极强,这些有机酸不仅能把血液中积存的乳酸排除体外,而且还能抑制新的乳酸产生,达到清洁血液的作用,而丰富的VB2又具有防止癌变的作用。
蜂王浆中含有的超氧化物歧化酶具有抗氧化作用,可辅助降低血糖。
黄芪 甘,微温。归脾、肺经。补脾肺气,升阳举陷,益卫固表,利尿,托毒生肌。含氨基酸、粘液质、糖类、苦味素、胆碱甜菜碱叶酸、熊竹素,β-谷甾醇 黄芪能增强网状内皮系统的吞噬功能,黄芪对干扰素系统有促进作用。黄芪及
黄芪多糖以使动物脾内浆细胞增生,促进抗体合成,对体液免疫有促进作用。
当归 甘、辛,温。归肝、心、大肠经。补血,活血,止痛,润肠通便。含挥发油、脂 肪油、维生素A类物质、维生素B12、维生素E、β-谷甾醇、阿魏酸等。当归尾热水煎煮液,浓缩后进行体外抗癌筛选试验,发现以人子宫颈癌JTC-26抑制率达70%-90%。
三七性味归经甘、微苦,微温。归肝、胃经。 功能主治化瘀止血,活血消肿定痛。主治各种出血证,跌仆瘀肿,胸痹心痛。 三七皂甙Rd能使培养的肿瘤细胞92%受到抑制,Rd对培养的瘤细胞也有明显抑制作用。皂甙Rhl可抑制小鼠黑色素瘤 (B16)的生长,使癌细胞再分化诱导逆转成非癌细胞,临床应用临床上常用治肺癌、食管癌、宫颈癌等癌瘤属瘀血阻滞或兼出血者。
绞股蓝性寒、味甘,有益气,安神,降血压之功效,民间称其为“神奇”的“不老长寿药草”。 实验证实,服用绞股蓝可明显抑制瘤细胞DNA合成,提高外周血中细胞 总数、TH细胞、B细胞总数、IgM、IgG,在抑制肿瘤的同时提高免疫,双管齐下,抗肿瘤效果更好。绞股蓝在治疗肝癌, 结肠癌,肺癌等多种恶性肿瘤上有一定的功效。
长期饮用本发明制出的口服液能使人体具有抗癌能力,增强免疫力,无任何副作用和不良反应,口味酸甜,能防止外界病毒对人体造成的伤害,同时还能起到降压、降血脂的功效。
具体实施方式
一种抗癌保健口服液,其特征在于:其组成为:
每200ml抗癌保健口服液中含有:
大蒜 10-25g
生姜 10-25g
酸梅 10-25g
蜂王浆 10-15g
中草药液 50ml
苹果醋 150ml
其中,所述中草药液所含组分为:
黄芪 5-10g
当归 5-10g
三七 5-10g
纹股蓝 5-10g
一种保健口服液的制作方法,其特征在于:
c、中草药液的制备:取黄芪5-10g、当归5-10g、三七5-10g、纹股蓝5-10g洗净后进行煎煮,浓缩至50ml备用;
b、将100ml苹果醋、50ml中草药液混合,加入10-15g蜂王浆混合均匀,放入大蒜10-25g、生姜10-25g、酸梅10-25g,低温杀菌后,在2-3℃下浸泡10-15天,滤除大蒜、生姜、酸梅,装入瓶中即可。
Claims (2)
1.一种抗癌保健口服液,其特征在于:其组成为:
每200ml抗癌保健口服液中含有:
大蒜 10-25g
生姜 10-25g
酸梅 10-25g
蜂王浆 10-15g
中草药液 50ml
苹果醋 150ml
其中,所述中草药液所含组分为:
黄芪 5-10g
当归 5-10g
三七 5-10g
纹股蓝 5-10g。
2.一种保健口服液的制作方法,其特征在于:
a、中草药液的制备:取黄芪5-10g、当归5-10g、三七5-10g、纹股蓝5-10g洗净后进行煎煮,浓缩至50ml备用;
b、将100ml苹果醋、50ml中草药液混合,加入10-15g蜂王浆混合均匀,放入大蒜10-25g、生姜10-25g、酸梅10-25g,低温杀菌后,在2-3℃下浸泡10-15天,滤除大蒜、生姜、酸梅,装入瓶中即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310670653.6A CN103610200A (zh) | 2013-12-12 | 2013-12-12 | 一种抗癌保健口服液及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310670653.6A CN103610200A (zh) | 2013-12-12 | 2013-12-12 | 一种抗癌保健口服液及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103610200A true CN103610200A (zh) | 2014-03-05 |
Family
ID=50160936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310670653.6A Pending CN103610200A (zh) | 2013-12-12 | 2013-12-12 | 一种抗癌保健口服液及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103610200A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103859518A (zh) * | 2014-03-31 | 2014-06-18 | 兰州乐赛特食品饮料有限公司 | 一种预防心脑血管疾病的果蔬汁饮品及其制备方法 |
CN103861070A (zh) * | 2014-03-14 | 2014-06-18 | 兰州乐赛特食品饮料有限公司 | 一种预防和治疗血管硬化的保健品及其制备方法 |
CN103948118A (zh) * | 2014-04-30 | 2014-07-30 | 桂林军供生化技术开发有限公司 | 一种预防和治疗高血脂液及其制备方法 |
CN104116111A (zh) * | 2014-06-13 | 2014-10-29 | 河南省淼雨饮品股份有限公司 | 一种降血脂及软化血管功能的保健饮料及其制备方法 |
CN106036830A (zh) * | 2016-05-26 | 2016-10-26 | 惠州同富康生物科技有限公司 | 含有青梅提取物的组合物的新用途 |
CN106692932A (zh) * | 2017-01-11 | 2017-05-24 | 葛龙海 | 口服液 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62107781A (ja) * | 1985-11-05 | 1987-05-19 | Nakano Vinegar Co Ltd | 食酢飲料 |
JPH06153876A (ja) * | 1992-11-27 | 1994-06-03 | Takehiko Otsuka | 花粉症の治療に有効な清涼飲料水の製造方法 |
CN101536781A (zh) * | 2009-03-31 | 2009-09-23 | 如皋市灵通酿造厂 | 一种保健饮料及制作方法 |
CN102266104A (zh) * | 2010-12-20 | 2011-12-07 | 李良 | 当归苹果醋饮料及其制备方法 |
CN102805190A (zh) * | 2012-07-27 | 2012-12-05 | 蚌埠丰润食品有限公司 | 一种核桃花养生棒棒糖 |
CN102860542A (zh) * | 2011-07-05 | 2013-01-09 | 姜倩雯 | 一种饮料及其加工工艺 |
-
2013
- 2013-12-12 CN CN201310670653.6A patent/CN103610200A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62107781A (ja) * | 1985-11-05 | 1987-05-19 | Nakano Vinegar Co Ltd | 食酢飲料 |
JPH06153876A (ja) * | 1992-11-27 | 1994-06-03 | Takehiko Otsuka | 花粉症の治療に有効な清涼飲料水の製造方法 |
CN101536781A (zh) * | 2009-03-31 | 2009-09-23 | 如皋市灵通酿造厂 | 一种保健饮料及制作方法 |
CN102266104A (zh) * | 2010-12-20 | 2011-12-07 | 李良 | 当归苹果醋饮料及其制备方法 |
CN102860542A (zh) * | 2011-07-05 | 2013-01-09 | 姜倩雯 | 一种饮料及其加工工艺 |
CN102805190A (zh) * | 2012-07-27 | 2012-12-05 | 蚌埠丰润食品有限公司 | 一种核桃花养生棒棒糖 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103861070A (zh) * | 2014-03-14 | 2014-06-18 | 兰州乐赛特食品饮料有限公司 | 一种预防和治疗血管硬化的保健品及其制备方法 |
CN103861070B (zh) * | 2014-03-14 | 2017-05-24 | 甘肃天然源生物科技有限公司 | 一种预防血管硬化的保健品 |
CN103859518A (zh) * | 2014-03-31 | 2014-06-18 | 兰州乐赛特食品饮料有限公司 | 一种预防心脑血管疾病的果蔬汁饮品及其制备方法 |
CN103859518B (zh) * | 2014-03-31 | 2015-05-20 | 兰州乐赛特食品饮料有限公司 | 一种预防心脑血管疾病的果蔬汁饮品及其制备方法 |
CN103948118A (zh) * | 2014-04-30 | 2014-07-30 | 桂林军供生化技术开发有限公司 | 一种预防和治疗高血脂液及其制备方法 |
CN104116111A (zh) * | 2014-06-13 | 2014-10-29 | 河南省淼雨饮品股份有限公司 | 一种降血脂及软化血管功能的保健饮料及其制备方法 |
CN106036830A (zh) * | 2016-05-26 | 2016-10-26 | 惠州同富康生物科技有限公司 | 含有青梅提取物的组合物的新用途 |
CN106692932A (zh) * | 2017-01-11 | 2017-05-24 | 葛龙海 | 口服液 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103610200A (zh) | 一种抗癌保健口服液及其制作方法 | |
CN103725573B (zh) | 一种龙桂酒及其制备方法 | |
CN104666768B (zh) | 一种用于滋养气血的中药保健制剂 | |
CN104109609A (zh) | 糯米酒荞麦果汁饮料及其制备方法 | |
CN103920065B (zh) | 一种抗衰老的中药组合物 | |
CN104988025A (zh) | 保肝护肝药酒 | |
CN102133352B (zh) | 一种预防、治疗肿瘤疾病的芦笋口服液药物及其制备方法 | |
CN103768198A (zh) | 咖啡灌肠液的制作方法 | |
CN106421519A (zh) | 一种保健药酒 | |
CN104041907B (zh) | 一种护肝解毒功能饮料及其制备方法 | |
CN101971977B (zh) | 一种基于恶性肿瘤化疗患者的营养食品 | |
CN105361152A (zh) | 一种硒维保健品及其制备方法 | |
CN104432239A (zh) | 一种鲟鱼丸食品 | |
CN103351988A (zh) | 银杏保健酒的制作方法 | |
CN107183427A (zh) | 一种石斛汁及其制备方法 | |
CN103519290A (zh) | 一种番茄汁 | |
CN104473235A (zh) | 保健鳝鱼丸食品 | |
CN104489773A (zh) | 保健草鱼丸食品 | |
CN104938682A (zh) | 四季茶强身保健饮料 | |
CN104489815A (zh) | 保健橙汁 | |
CN102631629B (zh) | 一种治疗肝气乘脾型结肠炎的中药制备方法 | |
CN104473234A (zh) | 保健鳙鱼丸食品 | |
CN107441270A (zh) | 一种用于中老年人慢性疾病的中药组合产品及制备方法 | |
CN104522174A (zh) | 一种保健鹿奶 | |
CN104489814A (zh) | 保健椰汁 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140305 |